UMIN-CTR Clinical Trial

Basic information
Public title	miRNA analysis of the CSF from the patients with neurodegenerative diseases
Acronym	miRNA of the neurodegenerative diseases
Scientific Title	miRNA analysis of the CSF from the patients with neurodegenerative diseases
Scientific Title:Acronym	miRNA of the neurodegenerative diseases
Region	Japan

Condition
Condition	Parkinson's disease, multiple system atrophy
Classification by specialty	Neurology Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	identification of the biomarker associated the neurodegenerative disease
Basic objectives2	Others
Basic objectives -Others	identification of the biomarker associated the neurodegenerative disease
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	none
Key secondary outcomes

Base
Study type	Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	80 years-old >=
Gender	Male and Female
Key inclusion criteria	Parkinson's disease or multiple system atrophy patients
Key exclusion criteria	under treated
Target sample size	70

Research contact person
Name of lead principal investigator	1st name Naoto Middle name Last name Sugeno
Organization	Tohoku University
Division name	Dept. ot Neurology
Zip code	980-8574
Address	1-1, Seiryo-machi, Aoba-ku, Sendai city, Japan
TEL	022-717-7189
Email	sugeno@med.tohoku.ac.jp

Public contact
Name of contact person	1st name Naoto Middle name Last name Sugeno
Organization	Tohoku University
Division name	Dept. of Neurology
Zip code	980-8574
Address	1-1, Seiryo-machi, Aoba-ku, Sendai city, Japan
TEL	022-717-7189
Homepage URL
Email	sugeno@med.tohoku.ac.jp

Sponsor
Institute	Tohoku University, School of Medicine
Institute
Department

Funding Source
Organization	Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization	Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Tohoku university, Dept of Neurology
Address	1-1, Seiryo-machi, Aoba-ku, Sendai city, Japan
Tel	022-717-7189
Email	sugeno@med.tohoku.ac.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2011 Year 11 Month 20 Day

Related information
URL releasing protocol	none
Publication of results	Unpublished

Result
URL related to results and publications	none
Number of participants that the trial has enrolled	0
Results	undone
Results date posted	2021 Year 11 Month 22 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics	not applicated
Participant flow	not applicated
Adverse events	not applicated
Outcome measures	not applicated
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2011 Year 11 Month 20 Day
Date of IRB	2011 Year 11 Month 22 Day
Anticipated trial start date	2011 Year 12 Month 01 Day
Last follow-up date	2011 Year 12 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	analyses of miRNA

Management information
Registered date	2011 Year 11 Month 15 Day
Last modified on	2021 Year 11 Month 22 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000007929